Gene therapy maker bluebird to go private in discounted deal amid cash crunch
Gene therapy maker bluebird bio on Friday agreed to be taken private by Carlyle and SK Capital Partners at a discount, ending ...
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.
'Life-changing' gene therapy for children born blind
An experimental trial of gene therapy has helped four toddlers - born with one of the most severe forms of childhood ...
6-Year-Old Boy Who Was Born Blind Gets Vision Partially Restored After ‘Life-Changing’ Gene Therapy
Jace, from Connecticut, is one of four children all born with severe childhood blindness who gained 'life-changing ...
The Economist4h
Gene editing has put biological research on a new trajectory
When the monkeys were single-celled embryos, scientists had used CRISPR editing tools to silence, or “knock out”, a gene that ...
Pfizer shelves haemophilia gene therapy Beqvez amid low demand
Pfizer will end the global commercialisation of its haemophilia gene therapy Beqvez (fidanacogene elaparvovec) amid low ...
FiercePharma7h
Pfizer discontinues hemophilia treatment Beqvez, emptying its gene therapy portfolio
Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...
GlobalData on MSN11h
Boehringer and partners commence gene therapy trial for cystic fibrosis
Boehringer Ingelheim, the UK Respiratory Gene Therapy Consortium (GTC), IP Group and Oxford BioMedica (OXB) have commenced ...
studyfinds on MSN5h
This one gene may explain why only humans can speak
Scientists have identified a tiny genetic change—present in nearly all living humans but absent in our closest extinct ...
stocknews2h
3 Gene Therapy Stocks With Game-Changing Potential
Gene therapy stocks are transforming healthcare with revolutionary treatments. Therefore, as this sector continues to evolve, ...
The Economist4h
Gene editing can still change the world
Like recombinant DNA before it, gene editing has the potential to transform medicine, agriculture and more. CRISPR is now used by thousands of biologists in labs across the globe. A revolution in food ...
How do cells respond to changes? New study finds it's not all in the genes
Cells are constantly on the move, whether in a developing embryo or metastatic cancer. But how do cells adapt to the new ...